Apotex is a Canadian pharmaceutical corporation. Founded in 1974, the company is the largest producer of generic drugs in Canada, with sales exceeding one billion dollars (CAD) a year. The company produces more than 300 generic pharmaceuticals in approximately 4000 dosages, exporting to over 115 countries around the globe. The company has two main divisions: medical research and development; and biotechnology. The biotechnology division is divided into three subsidiaries.
| Property | Value |
|---|
| dbpedia-owl:abstract
|
- Apotex is a Canadian pharmaceutical corporation. Founded in 1974, the company is the largest producer of generic drugs in Canada, with sales exceeding one billion dollars (CAD) a year. The company produces more than 300 generic pharmaceuticals in approximately 4000 dosages, exporting to over 115 countries around the globe. The company has two main divisions: medical research and development; and biotechnology. The biotechnology division is divided into three subsidiaries. Apotex owns 61% of Cangene Corp. , a Winnipeg-based biopharmaceutical company, according to Cangene's 2007 annual report. Cangene's business focuses are hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense against infectious diseases such as smallpox, hepatitis B and anthrax. Its products include WinRho SDF. Apotex has tied up with an Indian biopharmaceutical company, Intas Biopharmaceuticals, in April 2008 for developing generic version of blockbuster drug Filgrastim for US, Canadian and European market. In 1991, Apotex opened Apotex Fermentation in Winnipeg to develop fermentation-based technologies for the production of Active Pharmaceutical Ingredients (APIs) and to manufacture APIs for eventual sale as final dosage forms in Canada and internationally. The factory employs 150 people. In January 2004, ApoPharma was founded. Bernard (Barry) Sherman is the chairman and CEO and Jack M. Kay is the President. Apotex was recently warned by FDA for GMP issues (May 2010). See the Link here: http://fdanews. com/newsletter/article?issueId=13736&articleId=127459
|
| dbpedia-owl:formationYear
|
- 1974-01-01 00:00:00 (xsd:date)
|
| dbpedia-owl:industry
| |
| dbpedia-owl:keyPerson
| |
| dbpedia-owl:location
| |
| dbpedia-owl:numberOfEmployees
| |
| dbpedia-owl:product
| |
| dbpedia-owl:thumbnail
| |
| dbpedia-owl:type
| |
| dbpedia-owl:wikiPageExternalLink
| |
| dbpprop:companyLogo
| |
| dbpprop:companyName
| |
| dbpprop:companySlogan
| |
| dbpprop:companyType
| |
| dbpprop:foundation
| |
| dbpprop:homepage
| |
| dbpprop:industry
| |
| dbpprop:keyPeople
|
- Jack M. Kay, President
- Dr. Bernard Sherman, CEO
|
| dbpprop:location
| |
| dbpprop:numEmployees
| |
| dbpprop:products
| |
| dbpprop:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Apotex is a Canadian pharmaceutical corporation. Founded in 1974, the company is the largest producer of generic drugs in Canada, with sales exceeding one billion dollars (CAD) a year. The company produces more than 300 generic pharmaceuticals in approximately 4000 dosages, exporting to over 115 countries around the globe. The company has two main divisions: medical research and development; and biotechnology. The biotechnology division is divided into three subsidiaries.
|
| rdfs:label
| |
| owl:sameAs
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:name
| |
| foaf:page
| |
| is dbpedia-owl:wikiPageDisambiguates
of | |
| is dbpedia-owl:wikiPageRedirects
of | |
| is owl:sameAs
of | |
| is foaf:primaryTopic
of | |
